Skip to Main Content

Author Details

Ravi Bhatia
University of Alabama at Birmingham
1992
192
65
Jake Y. Chen (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36413413Low c-Kit expression identifies primitive, therapy-resistant CML stem cells.JCI Insight2023
36413413Low c-Kit expression identifies primitive, therapy-resistant CML stem cells.JCI Insight2023
36550214Microenvironmental CXCL12 deletion enhances Flt3-ITD acute myeloid leukemia stem cell response to therapy by reducing p38 MAPK signaling.Leukemia2023
36542864Synergistic effect of sequential solvent treatment on the structural and low temperature charge transport of PEDOT:PSS films.J Phys Condens Matter2023
36550214Microenvironmental CXCL12 deletion enhances Flt3-ITD acute myeloid leukemia stem cell response to therapy by reducing p38 MAPK signaling.Leukemia2023
36542864Synergistic effect of sequential solvent treatment on the structural and low temperature charge transport of PEDOT:PSS films.J Phys Condens Matter2023
35049365Safe and Effective Use of Imatinib to Treat Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia During Pregnancy.J Adolesc Young Adult Oncol2022
36855687Fano-Type Wavelength-Dependent Asymmetric Raman Line Shapes from MoS<sub>2</sub> Nanoflakes.ACS Phys Chem Au2022
36855378Bifunctional Application of Viologen-MoS<sub>2</sub>-CNT/Polythiophene Device as Electrochromic Diode and Half-Wave Rectifier.ACS Mater Au2022
35049365Safe and Effective Use of Imatinib to Treat Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia During Pregnancy.J Adolesc Young Adult Oncol2022
34962652Peripheral blood parameter abnormalities precede therapy-related myeloid neoplasms after autologous transplantation for lymphoma.Cancer2022
35263165Trends in Late Mortality and Life Expectancy After Autologous Blood or Marrow Transplantation Over Three Decades: A BMTSS Report.J Clin Oncol2022
36855687Fano-Type Wavelength-Dependent Asymmetric Raman Line Shapes from MoS<sub>2</sub> Nanoflakes.ACS Phys Chem Au2022
36855378Bifunctional Application of Viologen-MoS<sub>2</sub>-CNT/Polythiophene Device as Electrochromic Diode and Half-Wave Rectifier.ACS Mater Au2022
35263165Trends in Late Mortality and Life Expectancy After Autologous Blood or Marrow Transplantation Over Three Decades: A BMTSS Report.J Clin Oncol2022
34962652Peripheral blood parameter abnormalities precede therapy-related myeloid neoplasms after autologous transplantation for lymphoma.Cancer2022
32881995Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL.Blood2021
34120146Metabolic alterations mediated by STAT3 promotes drug persistence in CML.Leukemia2021
34260914TNF-α-induced alterations in stromal progenitors enhance leukemic stem cell growth via CXCR2 signaling.Cell Rep2021
32881995Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL.Blood2021
33420395Impact of access to care on 1-year mortality following allogeneic blood or marrow transplantation.Bone Marrow Transplant2021
34499078Trends in Late Mortality and Life Expectancy After Allogeneic Blood or Marrow Transplantation Over 4 Decades: A Blood or Marrow Transplant Survivor Study Report.JAMA Oncol2021
34597364Transcription factor MEF2D is required for the maintenance of MLL-rearranged acute myeloid leukemia.Blood Adv2021
34499078Trends in Late Mortality and Life Expectancy After Allogeneic Blood or Marrow Transplantation Over 4 Decades: A Blood or Marrow Transplant Survivor Study Report.JAMA Oncol2021
34597364Transcription factor MEF2D is required for the maintenance of MLL-rearranged acute myeloid leukemia.Blood Adv2021
34120146Metabolic alterations mediated by STAT3 promotes drug persistence in CML.Leukemia2021
34260914TNF-α-induced alterations in stromal progenitors enhance leukemic stem cell growth via CXCR2 signaling.Cell Rep2021
33420395Impact of access to care on 1-year mortality following allogeneic blood or marrow transplantation.Bone Marrow Transplant2021
31582541A high-content cytokine screen identifies myostatin propeptide as a positive regulator of primitive chronic myeloid leukemia cells.Haematologica2020
31901250Mesenchymal Niche-Specific Expression of Cxcl12 Controls Quiescence of Treatment-Resistant Leukemia Stem Cells.Cell Stem Cell2020
31582541A high-content cytokine screen identifies myostatin propeptide as a positive regulator of primitive chronic myeloid leukemia cells.Haematologica2020
32303152Collaborative cardiovascular management of patients with chronic myeloid leukemia on tyrosine kinase inhibitors.Vasc Med2020
31999305Expenditures for First- and Second-Generation Tyrosine Kinase Inhibitors Before and After Transition of Imatinib to Generic Status.JAMA Oncol2020
32460032CXCR4 Signaling Has a CXCL12-Independent Essential Role in Murine MLL-AF9-Driven Acute Myeloid Leukemia.Cell Rep2020
33022644Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw2020
32900849Exploitation of dihydroorotate dehydrogenase (DHODH) and p53 activation as therapeutic targets: A case study in polypharmacology.J Biol Chem2020
31999305Expenditures for First- and Second-Generation Tyrosine Kinase Inhibitors Before and After Transition of Imatinib to Generic Status.JAMA Oncol2020
31901250Mesenchymal Niche-Specific Expression of Cxcl12 Controls Quiescence of Treatment-Resistant Leukemia Stem Cells.Cell Stem Cell2020
32900849Exploitation of dihydroorotate dehydrogenase (DHODH) and p53 activation as therapeutic targets: A case study in polypharmacology.J Biol Chem2020
33022644Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw2020
32303152Collaborative cardiovascular management of patients with chronic myeloid leukemia on tyrosine kinase inhibitors.Vasc Med2020
32460032CXCR4 Signaling Has a CXCL12-Independent Essential Role in Murine MLL-AF9-Driven Acute Myeloid Leukemia.Cell Rep2020
30643249PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.Nat Genet2019
30643249PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.Nat Genet2019
31291568Mapping Distinct Bone Marrow Niche Populations and Their Differentiation Paths.Cell Rep2019
31180336SIRT1 regulates metabolism and leukemogenic potential in CML stem cells.J Clin Invest2019
31516189TARGETING LEUKEMIA STEM CELL RESISTANCE IN CHRONIC MYELOGENOUS LEUKEMIA.Trans Am Clin Climatol Assoc2019
30973642Medicare and patient spending among beneficiaries diagnosed with chronic myelogenous leukemia.Cancer2019
30905620Mesenchymal Niche-Specific Expression of Cxcl12 Controls Quiescence of Treatment-Resistant Leukemia Stem Cells.Cell Stem Cell2019
31412155Late mortality after bone marrow transplant for chronic myelogenous leukemia in the context of prior tyrosine kinase inhibitor exposure: A Blood or Marrow Transplant Survivor Study (BMTSS) report.Cancer2019
  • 1 - 50 of 384

Recommended Authors

University of Colorado Anschutz Medical Campus
Career Start Year 2009
Number of shared co-authors 4
University of Colorado School of Medicine
Career Start Year 2008
Number of shared co-authors 5
University Hospital TU Dresden
Career Start Year 2008
Number of shared co-authors 4
Universite de Paris, INSERM, CNRS
Career Start Year 2007
Number of shared co-authors 2
NYU Robert I. Grossman School of Medicine
Career Start Year 2006
Number of shared co-authors 3
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2006
Number of shared co-authors 11
Institute of Cancer Research
Career Start Year 2006
Number of shared co-authors 11
Graduate School of Medicine, The University of Tokyo
Career Start Year 2004
Number of shared co-authors 0
College of Medicine, University of Florida
Career Start Year 2003
Number of shared co-authors 8
Huntsman Cancer Institute, The University of Utah
Career Start Year 2001
Number of shared co-authors 6
Washington University School of Medicine
Career Start Year 2001
Number of shared co-authors 1
Children's Hospital of Philadelphia
Career Start Year 1999
Number of shared co-authors 4
Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 9
University of California Irvine
Career Start Year 1998
Number of shared co-authors 6
University of Colorado School of Medicine
Career Start Year 1998
Number of shared co-authors 4
University of Cambridge
Career Start Year 1996
Number of shared co-authors 8
Hannover Medical School
Career Start Year 1993
Number of shared co-authors 10
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Career Start Year 1992
Number of shared co-authors 6
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1991
Number of shared co-authors 13
Cincinnati Children's Hospital Medical Center
Career Start Year 1990
Number of shared co-authors 5
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 12
Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin
Career Start Year 1989
Number of shared co-authors 2
Universite de Montreal
Career Start Year 1988
Number of shared co-authors 5
University of Colorado, Aurora CO.
Career Start Year 1987
Number of shared co-authors 6
University of Texas Southwestern Medical Center
Career Start Year 1987
Number of shared co-authors 16
Sidney Kimmel Cancer Center, Johns Hopkins University
Career Start Year 1986
Number of shared co-authors 7
Princess Margaret Cancer Centre
Career Start Year 1985
Number of shared co-authors 4
University of Adelaide
Career Start Year 1984
Number of shared co-authors 11
Oregon Health & Science University
Career Start Year 1978
Number of shared co-authors 32
Washington University School of Medicine
Career Start Year 1978
Number of shared co-authors 18

Collaborators

Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham
Co-authored papers 27
Co-authored papers 11
The University of Texas MD Anderson Cancer Center
Co-authored papers 9
Fred Hutchinson Cancer Center
Co-authored papers 8
University of California at San Francisco
Co-authored papers 6
University of Alabama at Birmingham
Co-authored papers 6
Georgia Cancer Center
Co-authored papers 5
St Jude Children's Research Hospital
Co-authored papers 4
St Jude Children's Research Hospital
Co-authored papers 4
University of Utah Huntsman Cancer Institute
Co-authored papers 4
Stanford University School of Medicine
Co-authored papers 4
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
The Ohio State Comprehensive Cancer Center
Co-authored papers 3
Dana-Farber Cancer Institute
Co-authored papers 3
Memorial Sloan-Kettering Cancer Center
Co-authored papers 3
University of California San Francisco
Co-authored papers 3
Universite de Montreal
Co-authored papers 2
St Jude Children's Research Hospital
Co-authored papers 2
Washington University School of Medicine
Co-authored papers 2
Co-authored papers 2
St. Jude Children's Research Hospital.
Co-authored papers 2
Baylor College of Medicine
Co-authored papers 2
University of Alabama at Birmingham
Co-authored papers 2
Colleges of Medicine, University of Florida
Co-authored papers 2
Boston Children's Hospital, Harvard Medical School
Co-authored papers 2
Changhai Hospital, Second Military Medical University
Co-authored papers 2
The Jackson Laboratory Cancer Center
Co-authored papers 2
University of Michigan Rogel Cancer Center.
Co-authored papers 2
University of Washington
Co-authored papers 2